Atlas Trials

Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 Years

Clinical trial NCT01706367 · COMPLETED

Trial details

NCT number
NCT01706367
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Clostridium Difficile Associated Disease
Start date
2012-09-01
Primary completion
2014-01-01
Enrollment
192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.